Memantine as adjunctive treatment to atypical antipsychotics in schizophrenia patients

Details for Australian Patent Application No. 2005271906 (hide)

Owner Forest Laboratories, Inc.

Inventors Jonas, Jeffery; Gage, Allyson

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2005271906

PCT Pub. Number WO2006/017188

Priority 60/586,553 09.07.04 US

Filing date 7 July 2005

Wipo publication date 16 February 2006

International Classifications

A61K 31/13 (2006.01) - Amines, e.g. amantadine

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 25/18 (2006.01) Drugs for disorders of the nervous system

Event Publications

1 February 2007 PCT application entered the National Phase

  PCT publication WO2006/017188 Priority application(s): WO2006/017188

17 September 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005271912-Method for managing inter-zone bandwidth in a two-way messaging network

2005271902-Hybrid proteins with erbB4 extracellular domain and neuregulin heparin-binding domain for targeting